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Abstract The anticholinesterase paraoxon (Pxn) is related to
military nerve agents that increase acetylcholine levels, trigger
seizures, and cause excitotoxic damage in the brain. In rat
hippocampal slice cultures, high-dose Pxn was applied
resulting in a presynaptic vulnerability evidenced by a 64%
reduction in synapsin IIb (syn IIb) levels, whereas the post-
synaptic protein GluR1 was unchanged. Other signs of Pxn-
induced cytotoxicity include the oxidative stress-related pro-
duction of stable 4-hydroxynonenal (4-HNE)-protein adducts.
Next, the Pxn toxicity was tested for protective effects by the
fatty acid amide hydrolase (FAAH) inhibitor AM5206, a com-
pound linked to enhanced repair signaling through the
endocannabinoid pathway. The Pxn-mediated declines in
syn IIb and synaptophysin were prevented by AM5206 in
the slice cultures. To test if the protective results in the slice
model translate to an in vivomodel, AM5206was injected i.p.
into rats, followed immediately by subcutaneous Pxn admin-
istration. The toxin caused a pathogenic cascade initiated by
seizure events, leading to presynaptic marker decline and
oxidative changes in the hippocampus and frontal cortex.
AM5206 exhibited protective effects including the reduction
of seizure severity by 86%, and improving balance and coor-
dination measured 24 h post-insult. As observed in hippocam-
pal slices, the FAAH inhibitor also prevented the Pxn-induced
loss of syn IIb in vivo. In addition, the AM5206 compound
reduced the 4-HNE modifications of proteins and the β1
integrin activation events both in vitro and in vivo. These
results indicate that Pxn exposure produces oxidative and syn-
aptic toxicity that leads to the behavioral deficits manifested
by the neurotoxin. In contrast, the presence of FAAH inhibitor
AM5206 offsets the pathogenic cascade elicited by the Pxn
anticholinesterase.
Keywords Paraoxon .Anticholinesterase . Synaptic decline .
AM5206 . Neuroprotection . Excitotoxicity
Introduction
Increased activation of acetylcholine receptors has been asso-
ciated with excitotoxic damage in the central nervous system
(Prager et al. 2015). Neurotoxic agents such as paraoxon
(Pxn) and chlorpyrifos, one of the most widely used pesticides
in the world (Reynolds 2017), inhibit the enzyme acetylcho-
linesterase which leads to an accumulation of acetylcholine in
synapses and subsequent overstimulation of cholinergic re-
ceptors. As a result, the cholinergic crisis triggers seizures,
long-term behavioral changes, and reduces cognition (see
Sánchez-Santed et al. 2004; Prager et al. 2015). The important
issue of toxicity in humans and animals is due to the organo-
phosphates and their metabolites having relatively low level of
surveillance system regarding their use.
The danger of anticholinesterase toxins obviously includes
the occurrence of lethality. Asymptomatic low-level
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exposures can also leave the brain vulnerable to subsequent
brain insults such as traumatic injury, stroke events, and sei-
zures (see Munirathinam and Bahr 2004). This reinforces the
idea that certain neurotoxins like Pxn have actions beyond
anticholinesterase effects, for example, other neurotransmitter
systems may be involved in the propagation of the brain dam-
age. Note, Pxn increases the release of glutamate in the hip-
pocampus (Kozhemyakin et al. 2010). Whereas, GABA up-
take was significantly reduced in both cerebral cortex and
hippocampus of Pxn-treated rats (Mohammadi et al. 2008).
In addition, the consequences of Pxn exposure can cause neu-
rological problems later in life, or disrupt developmental pro-
cesses underlying synaptic connectivity and cognitive ability
in children which appear to be particularly vulnerable to anti-
cholinesterase effects (Rotenberg and Newmark 2003). Thus,
Pxn insults appear to be linked with different alterations that
disturb cellular homeostasis.
Cannabinergic mechanisms of neuroprotection represent a
plausible strategy for neuronal maintenance and/or repair in
order to offset damage caused by toxin exposure and
excitotoxic insults (Fernandez-Ruiz et al. 2010; Naidoo et al.
2011). The endocannabinoid system has been linked to protec-
tive on-demand responses in the brain. It works against seizure
damage, stroke/ischemia, traumatic brain injury, and multiple
sclerosis (Bahr et al. 2006; Fernandez-Ruiz et al. 2010; Hwang
et al. 2010; Sagar et al. 2010; Rosenberg et al. 2017).
Endocannabinoid regulation occurs through the inhibition of
fatty acid amide hydrolase (FAAH) and monoacylglycerol li-
pase (MAGL), resulting in enhancing effects on anandamide
(AEA) and 2-arachidonoyl glycerol (2-AG), respectively.
Targeting the endocannabinoid-degrading enzyme FAAH
may be an ideal strategy to promote endogenous repair path-
ways to act against negative effects caused by Pxn. Here, we
utilized a member of the FAAH inhibitor group of agents that
have been developed, compounds that are known to increase
endogenous levels of AEA through FAAH inactivation
(Kathuria et al. 2003; Karanian et al. 2007).We tested whether
a reversible FAAH inhibitor, the trifluoromethyl ketone ana-
log AM5206, prevents pathogenic events triggered by the
anticholinesterase Pxn, focusing mainly in the hippocampus,
a brain region that exhibits a vulnerability to different types of
neuropathogeneses.
Materials and Methods
Sprague-Dawley rat litters and young Sprague-Dawley male
rats were obtained from Charles River Laboratories
(Wilmington, MA) and housed in accordance with guidelines
from the National Institutes of Health. Brain tissue from 12-
day-old rats was rapidly removed to prepare hippocampal slices
as described previously (Bendiske et al. 2002; Karanian et al.
2005a). Transverse slices (400 μm) were quickly prepared, and
the hippocampal slices were kept in ice-cold buffer until groups
of eight to nine slices were placed on the Biopore PTFE mem-
brane of each Millicell-CM culture insert (Millipore, Billerica,
MA). Media was changed periodically, consisting of 50% basal
medium Eagle (Sigma-Aldrich, St. Louis, MO), 25% Earle’s
balanced salts (Sigma-Aldrich), 25% horse serum (Gemini Bio-
Products, Sacramento, CA), and defined supplements, as de-
scribed previously (Bendiske et al. 2002; Butler et al. 2007).
The hippocampal slices were maintained at 37 °C in 5% CO2-
enriched atmosphere for an 18–20-day maturation period be-
fore being treated with different agents.
Cultured hippocampal slices were pre-treated for 1 h with
media plus 0.02% DMSO, in the absence or presence of
20 μM AM5206. Slices were subsequently treated with vehi-
cle or 200 μM Pxn (Tocris, Ellisville, MO), freshly prepared,
for 24 h in the absence or presence of 20 μM of AM5206.
Note, AM5206 is 280- to 480-fold more selective for FAAH
than monoacylglycerol lipase (Naidoo et al. 2011). After the
treatments, cultured slices were fixed in 4% paraformaldehyde
for histology or gently harvested from the inserts using ice-
cold isosmotic buffer containing 0.32 M sucrose, 5 mM
HEPES (pH 7.4), 1 mM EDTA, and 1 mM EGTA.
A group of cultured hippocampal slices fixed in 4% para-
formaldehyde were rinsed in PBS, blocked with 5% BSA in
PBS containing 0.1% TX-100 for 1 h. Following, the tissue
was incubated with anti-NeuN antibody (1:200, Abcam,
Cambridge, MA) and by the secondary antibody step (1:750,
Alexa Fluor-488, Molecular Probe, Thermo Scientific,
Rockford, IL), and Neurotrace 640/660 deep-red fluorescent
Nissl stain (1:100, Thermo-Scientific). A Nikon Eclipse Ti
confocal Microscope (Nikon Instruments Inc., Melville, NY)
was used for imaging. Analysis and edition were performed
with NIS-Elements AR (Nikon).
Sprague-Dawley male rats were injected intraperitoneal
(i.p.) with vehicle or with AM5206 in a DMSO-PBS solution
(50/50%), for a dose of 8.0 mg/kg. Following, the rats were
immediately injected subcutaneous (s.c.) with either vehicle
(100% corn oil, Sigma-Aldrich) or a dose of 0.3 mg/kg Pxn
(Tocris) for assessment of the acute response. The animals
were returned to their cages, and seizure activities were re-
corded for 4 h. Then, at 24 h after last injections, the rats were
subjected to behavioral assessment. The seizure activity was
rated by observers blinded to the treatment groups at 15-min
intervals for a maximum of 4 h according to a well-established
rating scale (Karanian et al. 2007; Naidoo et al. 2012). Note,
Pxn dosage range was initially tested between 0.3 and 0.8 mg/
kg. The dose of 0.3 mg/kg was chosen to elicit a brain insult
with no issues of lethality. A dose of 0.8 mg/kg produced
unsurvived seizures, prolonged higher than 20 h.
For behavioral testing, balance and coordination were exam-
ined using behavioral paradigms 24 h after injection procedures
as previously described (Karanian et al. 2005b, 2007). In the
rota-rod test, rats were first trained on a rotating cylinder
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(15 rpm) for 10 consecutive trials with a maximum of 10 s per
trial. The animals were allowed to rest, and then re-tested on the
rota-rod for three consecutive trials up to a maximum of 2 min.
The time the animal stayed on the rod was recorded and aver-
aged across the three trials. The second behavioral paradigm
was the balance beam in which rats were placed in the middle
of a suspended wooden bar (1.2-cm diameter) positioned 15 cm
above a padded surface. During this task, animals were assessed
for the time before falling from the bar, up to a maximum of
30 s per trial for each of three consecutive trials. Following, the
animals were anesthetized with isoflurane (Abbott
Laboratories, Chicago, IL), and the brains were quickly re-
moved and placed in ice-cold buffer with protease inhibitors.
The brain regions, hippocampus, and frontal cortex were dis-
sected out and kept frozen until to be assessed by immunoblot.
Proteins were immunoblotted using the tissue from hippo-
campal slice cultures and young rats. The samples were homog-
enized in lysis buffer consisting of 15 mM HEPES (pH 7.4),
0.5mMEDTA, 0.5mMEGTAwith protease inhibitors cocktail
(Sigma-Aldrich), sonicated, and followed by protein concentra-
tion determination using Pierce BCA Protein Assay (Thermo-
Scientific). Equal amounts of protein sample were denatured
for 5 min at 100 °C, separated by SDS-PAGE, and transferred
to nitrocellulose membranes (Bio-Rad, Hercules, CA). Next,
membranes were blocked with 5% non-fat dry milk for 1 h at
room temperature, followed by incubation with primary anti-
bodies against GluR1 (1:1000), synapsin II (1:1000), and
NCAM (1:200) from Millipore; actin (1:500, Sigma-
Aldrich); β1 integrin (1:1000), synaptophysin (1:1000) and 4-
HNE (1:500) from Abcam (Cambridge, MA). For secondary
antibody steps, goat anti-rabbit IgG (1:1800) and goat anti-
mouse IgG (1:1600) conjugatedwith alkaline phosphatase were
from Bio-Rad, or horseradish peroxidase-conjugated goat anti-
rabbit IgG (1:10,000) and goat anti-mouse IgG (1:6000) were
from Amersham GE Healthcare (Pittsburgh, PA); these steps
were used in 2% milk and incubated for 1 h at room tempera-
ture. Development of antigens used either the 5-bromo-4-
chloro-3-indolyl phosphate and nitroblue tetrazolium substrate
system or enhanced chemiluminescence reagent, followed by
analysis with Amersham Imager 600 (GE Healthcare). Stained
antigens were scanned at high resolution to determine integrat-
ed optical density (IOD) with BIOQUANT software (R&M
Biometrics, Nashville, TN). All the results were evaluated by
unpaired t tests or analyses of variance (ANOVA) followed by
post hoc tests using Prism software (GaphPad, San Diego, CA).
Results
Hippocampal slice cultures are well known for their mainte-
nance of three-dimensional native organization and circuitry.
The distinct laminar subfield and neuronal morphology of the
hippocampus were assessed in the slice (see Fig. 1). After the
maturation period of 18 days, mature brain tissue exhibiting
native features at high magnification was visualized in the
stratum pyramidale (Fig. 1b) and the stratum granulosum lay-
er of the dentate gyrus (Fig. 1c). To study direct effects of an
anticholinesterase on this brain tissue, the mature hippocam-
pal slices were exposed to Pxn dosages of 10, 50, 100, and
200 μM. Only the 200 μM dose exhibited a consistent effect
in regards the synaptic decline at 24 h post-application, lead-
ing to a reduction of the presynaptic marker synapsin IIb (syn
IIb) (Fig. 2a). Note, syn IIb was reduced by 64% in Pxn-
treated slice cultures (Fig. 2b, p = 0.0006). The synaptophysin
levels were also decreased by the acute Pxn exposure (see Fig.
3a). Interestingly, the slices exhibiting Pxn-induced presynap-
tic decline did not show any reduction in the postsynaptic
marker GluR1 (Fig. 2a and c). Another sign of Pxn-induced
Fig. 1 Hippocampal slice cultures maintain native neuronal organization
and density. Transverse slices of hippocampi were prepared from brain
tissue of 11-day-old rat pups and placed on Biopore inserts. The tissue
was immunostained with anti-NeuN antibody, and confocal imaging
showed the appearance of the disparate hippocampus subfields (a).
High magnification view of fluorescent Nissl stain shows normal neuro-
nal morphology after 18 days in culture in the stratum pyramidal layer
(sp; b) and stratum granulosum layer (sg; c), pseudocolored in green. Size
bar: a 500 μm and b and c 25 μm
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cytotoxicity was the oxidative stress-related production of sta-
ble 4-HNE-protein adducts released into the media (Fig. 2d).
Together, these results suggest that 200 μM Pxn may cause
neuronal compromise and increase oxidative stress products
in cultured hippocampal slices, and presynaptic markers ap-
pear to be more susceptible than postsynaptic markers.
As a test for neuroprotection, the hippocampal slices ex-
posed to Pxn were also treated with the FAAH inhibitor
AM5206, a compound that promotes protec t ive
endocannabinoid signaling and reduces excitotoxic damage
(see Karanian et al. 2005b; Naidoo et al. 2011). Here, we used
the same concentration of AM5206 used previously to prefer-
entially diminish FAAH activity as compared to little effect on
MAGL (Naidoo et al. 2011). First, cultured hippocampal
slices were pre-treated with AM5206 or vehicle for 1 h; then,
they were subjected to Pxn exposure with the continued pres-
ence of AM5206 or vehicle for 24 h. The data show that
AM5206 attenuates Pxn-induced synaptic deterioration by re-
storing syn IIb levels, and similar protection was found for
synaptophysin (Fig. 3a). The syn IIb levels were enhanced
3-fold when AM5206 was present during Pxn exposure in
comparison to Pxn alone (Fig. 3b, p < 0.01).
As expected from the above results, no change in
GluR1 was found in the Pxn-treated slices, and the addi-
tion of AM5206 also had no negative effect on the post-
synaptic marker (Fig. 3a). Interestingly, Pxn-induced pre-
synaptic marker loss was consistently found associated
with aberrant β1 integrin activation. As part of its neuro-
protective action, AM5206 modulated β1 integrin re-
sponses to levels comparable to those found in control
slices (Fig. 3a, p = 0.023). These data together attribute
the AM5206 protective response, which specifically tar-
gets FAAH to modulate endogenous cannabinoid signal-
ing (Naidoo et al. 2011). Noteworthy, evidence of protec-
tive responses by the endocannabinoid pathway was also
shown in other studies of excitotoxicity (Karanian et al.
2005b; Sagar et al. 2010; Naidoo et al. 2011, 2012;
Shubina et al. 2017).
Next, we tested whether the protective effects of
AM5206 in the slice model translate to protection in an
animal model. A dose-dependent effect for reducing sei-
zure severity was first established for AM5206 in a
Fig. 2 Pxn acute insult specifically reduces presynaptic marker and
displays oxidative stress products in hippocampal slice cultures. Slices
of hippocampus were maintained in culture for 18 days; then, the tissue
was exposed to 200 μMPxn for 24 h alongside vehicle-treated slices. The
slices were harvested into three groups of six to eight each, and equal
protein aliquots assessed for synaptic markers synapsin IIb (syn IIb) and
GluR1 by immunoblot (a). Immunoreactivities were normalized to their
respective controls, and percent ± SEM are shown for syn IIb (b) and
GluR1 (c). Unpaired t test: ***p < 0.001. Media samples from Pxn-
treated hippocampal slice cultures were assessed for 4-HNE-protein ad-
ducts, an indicator of oxidative stress (d). Position of molecular weight
standard is shown (kDa)
Fig. 3 Endocannabinoid enhancement pathway by FAAH inhibitor
prevents Pxn-induced presynaptic deterioration. Cultured hippocampal
slices were pre-treated with 20 μM of AM5206, a fatty acid amide hy-
drolase (FAAH) inhibitor, for 1 h alongside vehicle-treated slices follow-
ed by 200 μM of Pxn with AM5206 or vehicle for 24 h. The slices were
harvested into three groups of six to eight slices each and per condition,
and equal protein aliquots assessed for synapsin IIb (syn IIb),
synaptophysin (SNP), GluR1, β1integrin, and the load control actin by
immunoblot (a). The syn IIb levels were normalized to their respective
controls, and percent ± SEM are shown (b). Unpaired t test: **p < 0.01
compared to Pxn-treated slices
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kainate rat model in which the kainate-treated animals
expressed seizure scores of 2.8 ± 0.24 (n = 12), whereas
rats that also received 1 (n = 4), 5 (n = 5), or 8 mg/kg
AM5206 (n = 8) exhibited 25, 43, and 79% reductions in
mean seizure scores, respectively (ANOVA: p < 0.0001).
In addition, a dosage range of 0–15 mg/kg for safety as-
sessment was previously tested, and no behavioral abnor-
malities or seizures were observed across the 14-day pe-
riod, including any alteration in alanine aminotransferase
activity and blood urea nitrogen levels (Naidoo et al.
2011). Accordingly, the 8 mg/kg effective dose was tested
against Pxn exposure. Here, Pxn-treated rats exhibited
prolonged tonic-clonic convulsions and seizures that were
assessed with a 0–6 rating scale (Fig. 4a). Interestingly,
seizure severity was reduced by 86% when the FAAH
inhibitor AM5206 was pre-administered to the Pxn-
treated animals at the protective 8 mg/kg dose (Fig. 4a,
p < 0.001). Consistent with seizure attenuation, AM5206
also displayed behavioral protection; while Pxn exposure
caused a reduction in performance on the rota-rod para-
digm to assess balance and coordination, Pxn rats that
received pre-treatment with the AM5206 FAAH inhibitor
displayed nearly complete recovery in rota-rod perfor-
mance (Fig. 4b, p < 0.01). In addition, Pxn reduced bal-
ance beam performance, and significant improvement was
shown for those animals pre-treated with AM5206 (Fig.
4c). Therefore, AM5206 attenuated seizures and signifi-
cantly improved performance in both behavioral
paradigms.
To further evaluate the neuroprotection in vivo, we tested
whether AM5206 provides synaptic protection against the
Pxn administration. The evidence of disruption of synaptic
integrity found in slice cultures after Pxn exposure was also
found in Pxn-treated rats. Pxn reduced syn IIb levels in two
vulnerable brain regions—the hippocampus and frontal cor-
tex. In contrast, AM5206 protected the deterioration of the
presynaptic marker in both brain regions (Fig. 5a). Also, as
previously reported, the reduction in kainate-induced seizures
by 8 mg/kg AM5206 was associated with synaptic and behav-
ioral protection (Naidoo et al. 2011). FAAH inhibitor also
exhibited an ability to protect against secondary events asso-
ciated with the Pxn-induced cytotoxicity, in particular the ab-
errant activation of β1 integrin. As found in slice model, cor-
tical and hippocampal samples from Pxn-treated rats exhibited
up to 3-fold increases in β1 integrin levels, and these levels
were significantly reduced by AM5206 (Fig. 5a, p = 0.02). As
a final note, NCAM, a postsynaptic marker indicator, was
unchanged in both brain regions—the hippocampus and neo-
cortex (Fig. 5b). Such evidence further suggests that the syn-
aptic vulnerability caused by Pxn involves presynaptic
markers as previously observed in vitro.
Finally, to address whether AM5206 is effective in
reducing oxidative damage both in vitro and in vivo,
we assessed 4-HNE-protein adducts of 76 kDa. The 4-
HNE adducts were effectively reduced due to AM5206
treatment as compared to Pxn alone in the slice model
(Fig. 6a). Similarly, hippocampi from Pxn-treated rats
exhibited increased amounts of 4-HNE-protein adducts,
and the presence of AM5206 displayed protection
against the harmful production of 4-HNE modifications
in the Pxn-treated rats (Fig. 6b and c).
Discussion
The present study indicates that the neurotoxin Pxn elicits a
similar profile of synaptic toxicity in vitro and in vivo with
Fig. 4 In vivo Pxn exposure triggers seizures and behavioral
compromise although attenuated by AM5206 treatment. Young
Sprague-Dawley rats were injected i.p. with AM5206 (n = 5) alongside
vehicle-treated rats, followed immediately injected with Pxn s.c. (n = 4).
Seizures were scored by blinded raters over a 1-h period ± SEM (a). The
control group was normalized across 10 animals. Unpaired t test:
***p < 0.001 compared to Pxn group. Next, at 24 h post-injection, the
animals were evaluated with a rota-rod paradigm to assess their coordi-
nation, as determined by the mean time ± SEM maintaining coordinated
movement on a rod rotating at 15 rpm (b). Also, the animals were placed
on a narrow, suspended bar to assess the balance beam test, determined by
themean time ± SEM (c). Unpaired t test: *p < 0.05, **p < 0.01 compared
to Pxn group
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regards to the selective reduction in the presynaptic marker syn
IIb.Moreover, the in vivo decline in syn IIb levels was observed
in those Pxn-treated animals that presented seizures and behav-
ioral deficits. With the direct application of Pxn to the brain
tissue using slice cultures of hippocampi, the toxin produced a
significant reduction in syn IIb levels by 64%. This synaptic
disruption induced by Pxn can be compared to synaptic marker
declines reported in various excitotoxicity studies using hippo-
campal slice culture (Bahr et al. 2002; Karanian et al. 2005b;
Naidoo et al. 2012; Quintana et al. 2015; Piwońska et al. 2016).
It is noteworthy that synaptic damage has been postulated as an
early sign of toxicity that leads to neuronal dysfunction and
memory impairment (Raveh et al. 2002, 2003; Munirathinam
and Bahr 2004), and the hippocampus is a vulnerable brain
region susceptible to organophosphate compounds (Crino
et al. 2002; Harrison et al. 2004), particularly due to the high-
density cholinergic and glutamatergic innervations.
Pxn exposure causes the accumulation of acetylcholine and
subsequent signs of hypercholinergic syndrome (Marrs 1993;
Jamal 1997; Sánchez-Santed et al. 2004). Consistent with the
present results, disturbances associated with Pxn-mediated
excitotoxicity occurs principally through presynaptic mecha-
nisms (Kozhemyakin et al. 2010). Here, the hippocampal slice
model expressed a selective reduction in the syn IIb isoform
after Pxn exposure. Synapsin II is a synaptic vesicle-
associated protein suggested to be a central element in the
organization and regulation of the active pool of vesicles in
nerve terminals (Chi et al. 2001). Many of the molecular fea-
tures of synapsin II suggest that it plays a regulatory role in
vesicular mobilization involved in short-term synaptic depres-
sion and facilitation. In contrast to the syn IIb effect, no
change was found regarding the postsynaptic marker GluR1
in Pxn-treated slices. However, it has been shown that the
potent neurotoxin soman, another organophosphate, elicited
a reduction in GluR1 in hippocampal slices (Munirathinam
and Bahr 2004). In agreement with the Pxn effects on
GluR1, Mohammadi et al. (2016) observed no change in the
mRNA expression and protein levels of the neuronal
glutamate transporter in paraoxon-treated animals.
Assessment of the FAAH inhibitor AM5206 found substan-
tial protection against Pxn exposure by preserving syn IIb levels
in hippocampal slice cultures. Note, compromised syn IIb levels
were increased 3-fold by AM5206, repairing the presynaptic
marker to levels comparable to those in control slices. Similar
protection was evident with cannabinoid signaling activated by
low-dose Δ9-tetrahydrocannabinol (THC), reversing the age-
related decline in cognitive performance accompanied by en-
hanced expression of synapsin and synaptophysin in vivo
(Bilkei-Gorzo et al. 2017). In addition, the 4-HNE-protein ad-
ducts generated after Pxn exposure were decreased by the
FAAH inhibitor. The 4-HNE modification is widely accepted
as a marker of oxidative stress (Chen and Niki 2006), and 4-
HNE bound to proteins is considered the most likely form of 4-
HNE in cells. Thus, the AM5206 FAAH inhibitor appears to
offer an approach for modulating endocannabinoid signaling to
promote protection against Pxn-induced presynaptic vulnerabil-
ity and oxidative stress. The results further indicate that FAAH
Fig. 6 FAAH inhibitor elicits protection against oxidative stress products
after Pxn insult. Products of lipid peroxidation were assessed by 4-HNE-
protein adducts of 76 kDa (see arrows). First, cultured hippocampal slices
were pre-treated with AM5206 for 1 h alongside vehicle-treated slices
followed by Pxn with AM5206 or vehicle for 24 h, then harvested into
groups of six to eight slices each and assessed by immunoblot for 4-HNE
(a). In parallel, young Sprague-Dawley rats were injected i.p. with
AM5206 alongside vehicle-treated rats, followed immediately injected
with Pxn s.c. in both groups of three each. Following, the hippocampi
were dissected and assessed by immunoblots for 4-HNE-protein adducts
(b), and the levels for the in vivo study were plotted as mean percent of
control ± SEM (c). Unpaired t test: **p = 0.01 compared to Pxn group
Fig. 5 FAAH inhibitor prevents synaptic vulnerability after Pxn-induced
synaptotoxicity in vivo. Young Sprague-Dawley rats were injected i.p.
with AM5206 (n = 5) alongside vehicle-treated rats, followed immedi-
ately injected with Pxn s.c. (n = 4). Brain regions were dissected and
assessed by the immunoblots for synapsin IIb (syn IIb), load control actin,
and β1 integrin (a). Similarly, immunoblots were also assessed for neural
cell adhesion molecule (NCAM, b)
J Mol Neurosci
inhibition influences endogenous cannabinoids for homeostatic
regulat ion. Blocking FAAH is known to reduce
endocannabinoid deactivation, and the enhanced
endocannabinoid system mediates protection through pathways
linked to the CB1 receptor (see Galve-Roperh et al. 2002;
Molina-Holgado et al. 2005; Karanian et al. 2005b, 2007).
Hippocampal slice cultures are valuable for the analysis of
neuropathological events by reproducing the toxicological
changes as found in vivo (see Thompson et al. 1996; Karanian
et al. 2005a; Naidoo et al. 2012). The molecular indicators of
toxicity in the slice model were observed in the Pxn-treated rat
model as well. As in the slice culture results, the neuroprotection
assessed for FAAH inhibition also translated to the in vivo Pxn
model, thus indicating the usefulness of screening studies in cul-
tured tissue slices. Acute exposure to anticholinesterase agents is
well known to evoke seizure activity leading to neuronal damage
(Kozhemyakin et al. 2010, Ruban et al. 2015; Shrot et al. 2015).
As expected, in vivo Pxn exposure in the current study led to
seizure events and associated disruption in behavior. The
AM5206 FAAH inhibitor decreased the seizure scores in Pxn-
treated rats, producing suppression of seizure severity and atten-
uation of behavioral impairment in correspondence with evi-
dence of synaptic protection.
In both the slice and rat models, protecting presynapticmarker
levels was tied to the prevention and/or recovery of Pxn-induced
alterations to the β1-class integrin. The latter is part of a large
family of extracellular matrix receptors involved in a wide range
of synaptic integrin functions (Park and Goda 2016). The β1
integrin responses may be responsible for regulating the readily
releasable pool of synaptic vesicles (Huang et al. 2006), thus
connecting to the presynaptic vulnerability described. Noting that
neuronal stimulation activates β1 integrins in hippocampal syn-
apses (Babayan et al. 2012), the excitatory over-activation
through Pxn toxicity may be initiating a level of synaptic cofilin
and other signaling above that which maintains physiological
neurotransmission and plasticity (see Woo et al. 2015;
Lauterborn et al. 2017). Of the two cannabinoid CB1 receptor
(CB1R) signaling cascades recently identified (Wang et al.
2017), perhaps the protective endocannabinoid action of
AM5206 occurs through the cascade that is independent of co-
operative CBR1/β1 integrin responses.
Pxn exposure produced seizure events and behavioral com-
promise in correspondence with synaptic disturbance. AM5206
protected against the Pxn-induced deficits in balance and coor-
dination, and the improved behavior was accompanied by syn-
aptic protection indicated by levels of syn IIb. These data sug-
gest that the FAAH inhibitor is able to prevent presynaptic
deterioration, thereby reducing functional deficits. FAAH has
been localized postsynaptically within many brain regions, in-
cluding hippocampal and neocortical neuronal cell bodies (see
Egertova et al. 2003). In Pxn-treated rats, the presynaptic mark-
er syn IIb was reduced whereas 4-HNE-protein adducts were
enhanced, presenting the same profile as found in the
hippocampal slice model. FAAH inhibition appears to reduce
the sign of oxidative stress and prevent the negative impact on
synaptic function. Note, oxidative damage along with presyn-
aptic vulnerability during seizure events may be a pathogenic
combination that disrupts cellular homeostasis. Recently, an
in vivo study showed that the beneficial effects of THC canna-
binoid signaling are dependent on glutamatergic CB1 receptors
(Bilkei-Gorzo et al. 2017); thus, it is interesting that Pxn did not
reduce the glutamatergic marker GluR1, perhaps signifying that
this type of toxin has a higher probability of being treated
through the cannabinergic pathway and that FAAH inhibitors
can be helpful to combat neuropathogenic cascades.
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